Sign Out
Lincomycin therapy has been associated with severe colitis which may end fatally.
It should be reserved for serious infections where less toxic antimicrobial agents are inappropriate.
It should not be used in patients with nonbacterial infections, such as most upper respiratory tract infections.
Its use in newborns is contraindicated.
As this preparation contains benzyl alcohol, its use should be avoided in children less than two years of age. Not to be used in neonates.
